help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 5, 2005
Endocrinology, doi:10.1210/en.2005-0043
A more recent version of this article appeared on August 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/8/3286    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by IWASAKI, T.
Right arrow Articles by HATTORI, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by IWASAKI, T.
Right arrow Articles by HATTORI, H.

Submitted on January 13, 2005
Accepted on April 18, 2005

Deficiency of the Very Low-Density Lipoprotein (VLDL) Receptors In Streptozotocin-Induced Diabetic Rats: Insulin-Dependency of the VLDL Receptor

TADAO IWASAKI, SADAO TAKAHASHI*, MASAO TAKAHASHI, YASUO ZENIMARU, TAKESHI KUJIRAOKA, MITSUAKI ISHIHARA, MAKOTO NAGANO, JINYA SUZUKI, ISAMU MIYAMORI, HIRONOBU NAIKI, JURO SAKAI, TAKAHIRO FUJINO, NORMAN E. MILLER, TOKUO T. YAMAMOTO, and HIROAKI HATTORI

Insulin Dependency of the VLDL Receptor and LPL, and Partial Etiology of Insulin-Deficient Diabetic Hyperlipidemia; Department of Advanced Medical Technology and Development (T.I., T.K., M. I., M. N., H.H.), BML, Inc., Kawagoe, Japan; Third Department of Internal Medicine (S.T., Y.Z., J.S., I. M.), Faculty of Medical Sciences, University of Fukui, Fukui, Japan; Department of Cardiovascular Surgery (M.T.), Hiratsuka Kyosai Hospital, Hiratuka, Japan; Second Department of Pathology (H. N.), University of Fukui, Fukui, Japan; Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology (J.S.), University of Tokyo, Komaba, and Exploratory Research for Advanced Technology of Japan Science and Technology Corporation (J.S.), Aomi, Japan; Department of Bioscience (T.F.), Integrated Center for Science, Ehime University, Shigenobu, Japan; Department of Cardiovascular Biochemistry, St Barts and the Royal London School of Medicine, (N.E.M.), London, UK; Center for Advanced Genome Research, Institute of Aging, Development and Cancer (T.T.Y.), Tohoku University, Sendai, Japan

* To whom correspondence should be addressed. E-mail: sadaost{at}fmsrsa.fukui-med.ac.jp.

Hyperlipidemia is a common feature of diabetes and is related to cardiovascular disease. The very low-density lipoprotein receptor (VLDL-R) is a member of the low-density lipoprotein receptor (LDL-R) family. It binds and internalizes triglyceride (TG)-rich lipoproteins with high specificity. We examined the etiology of hyperlipidemia in insulin-deficient state. VLDL-R expression in heart and skeletal muscle were measured in rats with streptozotocin (STZ)-induced diabetes. STZ rats showed severe hyperlipidemia on day 21 and 28 with a dramatic decline in VLDL-R protein in skeletal muscle (>90%), heart (about 50%) and a loss of adipose tissues itself on day 28. The reduction of VLDL-R protein in skeletal muscle could not be explained simply by a decrease at transcriptional level, as the dissociation between VLDL-R protein and mRNA expression was observed. The expression of the LDL-R and LDL receptor-related protein (LRP1) in liver showed no consistent changes. Furthermore, no effect on VLDL-TG production in liver was observed in STZ rats. Post-heparin plasma lipoprotein lipase (LPL) activity was started to reduce on day 7 and continued to on day 28 at 50% level even though severe hyperlipidemia was detected only on day 21 and 28. In rat myoblast cells, serum deprivation for 24 h induced reduction of the VLDL-R proteins. Insulin (10-6 M) but not IGF-1 (10ng/ml) recovered the decreased VLDL-R proteins by serum deprivation. These results suggest that the combination of VLDL-R deficiency and reduced plasma LPL activity may be responsible for severe hyperlipidemia in insulin-deficient diabetes.


Key words: VLDL Receptor • STZ-Induced Diabetic Rats • Insulin-Dependency




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. An and B. Rodrigues
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Shinohara, N. Takahashi, T. Ooie, M. Hara, S. Shigematsu, M. Nakagawa, H. Yonemochi, T. Saikawa, and H. Yoshimatsu
Phosphatidylinositol 3-kinase-dependent activation of akt, an essential signal for hyperthermia-induced heat-shock protein 72, is attenuated in streptozotocin-induced diabetic heart.
Diabetes, May 1, 2006; 55(5): 1307 - 1315.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society